medigraphic.com
Revista Médica Sinergia

2023, Number 01

<< Back Next >>

Revista Médica Sinergia 2023; 8 (01)

Update on the approach of cutaneous melanoma

Obaldía MAP, Murillo BF, Cesare PS

Language: Spanish
References: 16
Page:
PDF size: 164.85 Kb.


ABSTRACT

Cutaneous melanoma is a disorganized and uncontrolled growth of melanocytes located in the epidermis. Melanomas can originate from existing pigmented lesions such as nevi or from ¨de novo¨ lesions. There are different predisposing factors for cutaneous melanoma, but the most important is the exposure to ultraviolet radiation. The diagnosis of cutaneous melanoma is always made with a biopsy of the suspicious lesion. The staging of melanoma skin cancer is complex and depends on many factors of the lesion reported by the pathologist after the biopsy. There are different therapeutic options for patients diagnosed with cutaneous melanoma, even for patients in advanced stages, in whom previously only benefited from palliative treatment.


REFERENCES

  1. Hartman RI, Lin JY. Cutaneous Melanoma—A Review in Detection, Staging, and Management. Vol. 33, Hematology/Oncology Clinics of North America. 2019;33(1):25–38. Doi: https://doi.org/10.1016/j.hoc.2018.09.005

  2. Strashilov S, Yordanov A. Aetiology and pathogenesis of cutaneous melanoma: Current concepts and advances. Int J Mol Sci. 2021 Jun 02;22(12). Doi: https://doi.org/10.3390/ijms22126395

  3. Garbe C, Amaral T, Peris K, Hauschild A, Arenberger P, Bastholt L, et al. European consensus-based interdisciplinary guideline for melanoma. Part 2: Treatment – Update 2019. Eur J Cancer. 2020 Feb 01;126:159–77. Doi: 10.1016/j.ejca.2022.04.018

  4. Michielin O, van Akkooi A, Ascierto P, Dummer R, Keilholz U. Cutaneous melanoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up † on behalf of the ESMO Guidelines Committee. Doi: doi/10.1093/annonc/mdz411/5578477

  5. Domingues B, Lopes J, Soares P, Pópulo H. Melanoma treatment in review. Immunotargets Ther. 2018, Jun;7:35–49. Doi: http://dx.doi.org/10.2147/ITT.S134842

  6. Leonardi GC, Falzone L, Salemi R, Zanghì A, Spandidos DA, Mccubrey JA, et al. Cutaneous melanoma: From pathogenesis to therapy (Review). International Journal of Oncology. Spandidos Publications. 2018;52:1071–80. Doi: 10.3892/ijo.2018.4287

  7. Castro e Souza B de, Morais Silva DH, Valente NYS, Kakizaki P, Luce MCA, Bandeira LG. Cutaneous melanoma: a retrospective study of 18 years. Are there gender differences? An Bras Dermatol. 2021, Sep 01;96(5):619–23. Doi: https://doi.org/10.1016/j.abd.2020.08.022

  8. Burns D, George J, Aucoin D, Bower J, Burrell S, Gilbert R, et al. The Pathogenesis and Clinical Management of Cutaneous Melanoma: An Evidence-Based Review. Journal of Medical Imaging and Radiation Sciences. 2019;50:460-469.e1. Doi: https://doi.org/10.1016/j.jmir.2019.05.001

  9. Prado G, Svoboda RM, Rigel DS. What’s New in Melanoma. Dermatologic Clinics. 2019;37(2):159–68. Doi: https://doi.org/10.1016/j.det.2018.12.005

  10. Elder DE, Bastian BC, Cree IA, Massi D, Scolyer RA. The 2018 World Health Organization classification of cutaneous, mucosal, and uveal melanoma detailed analysis of 9 distinct subtypes defined by their evolutionary pathway. Archives of Pathology and Laboratory Medicine. College of American Pathologists. 2020;144:500–22. Doi: 10.5858/arpa.2019-0561-RA

  11. Carr S, Smith C, Wernberg J. Epidemiology and Risk Factors of Melanoma. Surgical Clinics of North America. W.B. Saunders. 2020;100(1):1–12. Doi: https://doi.org/10.1016/j.suc.2019.09.005

  12. O’Neill CH, Scoggins CR. Melanoma. Journal of Surgical Oncology. 2019;120:873–81. Doi: https://doi.org/10.1002/jso.25604

  13. Swetter SM, Tsao H, Bichakjian CK, Curiel-Lewandrowski C, Elder DE, Gershenwald JE, et al. Guidelines of care for the management of primary cutaneous melanoma. J Am Acad Dermatol. 2019, Jan 01;80(1):208–50. Doi: https://doi.org/10.1016/j.jaad.2018.08.055

  14. Botella-Estrada R, Boada-García A, Carrera-Álvarez C, Fernández-Figueras M, González-Cao M, Moreno-Ramírez D, et al. Clinical Practice Guideline on Melanoma From the Spanish Academy of Dermatology and Venereology (AEDV). Actas Dermosifiliogr. 2021, Feb 01;112(2):142–52. Doi: https://doi.org/10.1016/j.ad.2020.07.003

  15. Tejera-Vaquerizo A, Fernández-Figueras MT, Santos-Briz Á, Ríos-Martín JJ, Monteagudo C, Fernández-Flores Á, et al. Protocol for the Histologic Diagnosis of Cutaneous Melanoma: Consensus Statement of the Spanish Society of Pathology and the Spanish Academy of Dermatology and Venereology (AEDV) for the National Cutaneous Melanoma Registry. Vol. 112, ACTAS Dermo-Sifiliográficas. 2021. http://creativecommons.org/licenses/by-nc-nd/4.0/

  16. Garbe C, Amaral T, Peris K, Hauschild A. European consensus-based interdisciplinary guideline for melanoma. Part 1: Diagnostics e Update 2019. Eur J Cancer. 2020, Jan 13;126:141–58. Doi: https://doi.org/10.1016/j.ejca.2019.11.014




2020     |     www.medigraphic.com